- Medical School - University of Michigan Medical School (2000-2010)
- Residency - UT Southwestern/Children's Medical Center (2010-2013), Pediatrics
- American Academy of Pediatrics (2010)
Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.
Graves CW, Philips ST, Bradley SV, Oravecz-Wilson KI, Li L, Gauvin A, Ross TS Cancer research 2008 Feb 68 4 1064-73
Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer.
Bradley SV, Oravecz-Wilson KI, Bougeard G, Mizukami I, Li L, Munaco AJ, Sreekumar A, Corradetti MN, Chinnaiyan AM, Sanda MG, Ross TS Cancer research 2005 May 65 10 4126-33
Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
Kalli KR, Bradley SV, Fuchshuber S, Conover CA Gynecologic oncology 2004 Sep 94 3 705-12
Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1.
Hyun TS, Li L, Oravecz-Wilson KI, Bradley SV, Provot MM, Munaco AJ, Mizukami IF, Sun H, Ross TS Molecular and cellular biology 2004 May 24 10 4329-40
Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors.
Rao DS, Chang JC, Kumar PD, Mizukami I, Smithson GM, Bradley SV, Parlow AF, Ross TS Molecular and cellular biology 2001 Nov 21 22 7796-806
Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor.
Bradley SV, Holland EC, Liu GY, Thomas D, Hyun TS, Ross TS Cancer research 2007 Apr 67 8 3609-15
Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells.
Rao DS, Bradley SV, Kumar PD, Hyun TS, Saint-Dic D, Oravecz-Wilson K, Kleer CG, Ross TS Cancer cell 2003 May 3 5 471-82
Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system.
Conover CA, Hartmann LC, Bradley S, Stalboerger P, Klee GG, Kalli KR, Jenkins RB Experimental cell research 1998 Feb 238 2 439-49
Aberrant Huntingtin interacting protein 1 in lymphoid malignancies.
Bradley SV, Smith MR, Hyun TS, Lucas PC, Li L, Antonuk D, Joshi I, Jin F, Ross TS Cancer research 2007 Sep 67 18 8923-31
Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1.
Bradley SV, Hyun TS, Oravecz-Wilson KI, Li L, Waldorff EI, Ermilov AN, Goldstein SA, Zhang CX, Drubin DG, Varela K, Parlow A, Dlugosz AA, Ross TS Human molecular genetics 2007 Jun 16 11 1279-92
HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains.
Hyun TS, Rao DS, Saint-Dic D, Michael LE, Kumar PD, Bradley SV, Mizukami IF, Oravecz-Wilson KI, Ross TS The Journal of biological chemistry 2004 Apr 279 14 14294-306
- Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.